Integrin α3β1 Represses Reelin Expression in Breast Cancer Cells to Promote Invasion

• Published in: Cancers Vol. 13; no. 2; p. 344
• Main Authors: Ndoye, Abibatou, Miskin, Rakshitha Pandulal, DiPersio, C Michael
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 19-01-2021; MDPI
• Subjects: Breast cancer; Cell adhesion; Cell adhesion & migration; Cell culture; DNA microarrays; Gene expression; Invasiveness; Kinases; Ligands; Medical prognosis; Medical research; Metastasis; mRNA; Reelin protein; RNA-mediated interference; Therapeutic targets; Tumor cell lines; RELN; Reelin; cancer cell secretome; invasion; integrin α3β1; triple negative breast cancer; tumor microenvironment
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers13020344

Integrin α3β1, a cell adhesion receptor for certain laminins, is known to promote breast tumor growth and invasion. Our previous gene microarray study showed that the RELN gene, which encodes the extracellular glycoprotein Reelin, was upregulated in α3β1-deficient (i.e., α3 knockdown) MDA-MB-231 cells. In breast cancer, reduced RELN expression is associated with increased invasion and poor prognosis. In this study we demonstrate that α3β1 represses RELN expression to enhance breast cancer cell invasion. RELN mRNA was significantly increased upon RNAi-mediated α3 knockdown in two triple-negative breast cancer cell lines, MDA-MB-231 and SUM159. Modulation of baseline Reelin levels altered invasive potential, where enhanced Reelin expression in MDA-MB-231 cells reduced invasion, while RNAi-mediated suppression of Reelin in SUM159 cells increased invasion. Moreover, treatment of α3β1-expressing MDA-MB-231 cells with culture medium that was conditioned by α3 knockdown MDA-MB-231 cells led to decreased invasion. RNAi-mediated suppression of Reelin in α3 knockdown MDA-MB-231 cells mitigated this effect of conditioned-medium, identifying secreted Reelin as an inhibitor of cell invasion. These results demonstrate a novel role for α3β1 in repressing Reelin in breast cancer cells to promote invasion, supporting this integrin as a potential therapeutic target.